Ph.D., CTO, OncoDNA
Jean-François did his PhD in cancer genetics at ULB (Université Libre de Bruxelles) and then worked at the Jules Bordet Institute where he set up an Affymetrix microarray platform for use in translational research and clinical studies. In 2004 he co-founded DNAVision, a company with the goal of becoming a leader in DNA / RNA analysis in a high quality environment (ISO17025 / GLP / GMP). In 2011 he became a Support Specialist for Ion Torrent technologies at Life Technologies. At the beginning of 2013, Jean-François joined OncoDNA as Chief Technology Officer. He is one of those responsible for the research and development of new products, services and software.
Liquid biopsy in One Clinical’s Patient Trial Paradigm
Every patient is unique and the evolution of his tumor too. We need better solutions to characterize, treat, monitor and finally track down such disease. Based on the One clinical’s patient trial approach, available information and technologies, a personalized molecular passport from tumor characterization to its monitoring should be built for a true personalized monitoring of patient’s outcomes.